March 18, 2019, Basel, Switzerland and Erlanger, Kentucky, USA – Orphanion AG, a CRO/CMO that focuses on contract research and manufacturing services for niche active pharmaceutical ingredients (APIs), and LGM Pharma, LLC, a leader in API sourcing, warehousing and distribution services to the pharmaceutical and biotechnology industries, today announced that they have finalized a partnering[…]
ORPHANION Partners with API Sourcing Leader LGM Pharma to Expand Global Access to Its Niche API Services
LGM Pharma, Press Release Tags: CMOCRAMSCROORPHANIONPartnership Mar 18, 2019
Hamilton Lenox Joins LGM Pharma as Senior VP of Business Development
LGM Pharma, Press Release Tags: business developmentHamilton J. LenoxHamilton Lenox Feb 07, 2019
ERLANGER, Kentucky / BOCA RATON, Florida — LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Hamilton J. Lenox as Senior Vice President of Business Development at the Boca Raton, Florida location. In this capacity, Mr. Lenox will[…]
Dactinomycin: An Old Chemotherapy API with New Demand
Antibiotic Tags: antibioticcancer treatmentchemotherapy Jan 16, 2019
Dactinomycin: CAS No: 50-76-0 No: 50-76-0 Dactinomycin (or actinomycin D) was the very first known antibiotic that helped fend off cancer. It’s now a standard chemotherapy medication being used to treat a variety of tumorous diseases. Doctors will typically reach for dactinomycin for sarcoma, ovarian cancer, and Wilm’s tumor. It can also be used with certain types of neoplasia and skin moles. The[…]
Sumatriptan: An Effective Choice to Fight Migraines and Cluster Headaches
Anti-Migraine, Compounding API Tags: migrainesserotonin Dec 28, 2018
Sumatriptan CAS #: 103628-46-2 Sumatriptan is an API that works with the serotonin neurons in the brain to fight migraines and cluster headaches. By constricting the blood vessels in the brain back to their normal size and preventing the trigeminal nerve from firing at full force, sumatriptan is designed to stop symptoms as soon as they start.[…]
Donepezil HCl – Alleviating Dementia Symptoms
Anti-Alzheimer's, Antidimentia Tags: Alzheimers diseaseDementiaDonepezil Dec 20, 2018
Donepezil HCl CAS #: 120011-70-3 Donepezil HCl was first approved in the US by the FDA in 1983. It’s since seen tremendous success with the branded version of the API (Aricept) becoming the number-one selling medication for treatment of Alzheimer’s since 2011. According to current data, the brand is still very strong, worth close to[…]
Cetrorelix: A Fertility Drug that Shows Promise to Treat Pregnant Women with PCOS in the Future
Hormonal Agent, Synthetic Peptide Tags: PCOSPolycystic Ovarian SyndromePregnancy Dec 12, 2018
Cetrorelix CAS No: 120287-85-6 Cetrorelix is traditionally used as fertility API that binds to a hormone receptor to stop gonadotropin secretion. While it may be associated with women undergoing ovarian stimulation, it appears as though there’s more to this API that meets the eye. This synthetic decapeptide is being studied to help with a variety of conditions, including the[…]
Sirolimus Provides Protection for the Heart, Kidneys, and Lungs
Immunosuppressant Tags: Sirolimus Dec 05, 2018
Sirolimus CAS No: 53123-88-9 First discovered in 1972 and approved by the FDA in 1999, sirolimus can be used for a variety of disorders and medical events, including organ transplant procedures, lung disease, and heart protection. By suppressing the immune system, patients who have recently received a new organ have a better chance of their body accepting[…]
Apomorphine HCl: A Promising Drug to Help Parkinson’s Patients
Anti-Parkinsons Tags: Apomorphine Nov 14, 2018
Apomorphine HCl CAS: 41372-20-7 Apomorphine HCl is a versatile API commonly associated with treating Parkinson’s disease. When those who suffer from Parkinson’s have difficulty walking or speaking, they can take apomorphine as a means to gain control over their movements. It can’t prevent the episodes, but it can make it easier to handle the symptoms[…]
Joseph Gelfand Joins LGM Pharma as VP of Supply Chain and Sales Operations
LGM Pharma, Press Release Tags: Joseph Gelfand Nov 12, 2018
ERLANGER, Kentucky / BOCA RATON, Florida — LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Mr. Joseph Gelfand as Vice President of Supply Chain and Sales Operations at the Boca Raton, Florida location. In this capacity, Mr.[…]
A Controversial API with Plenty of Promise: Naltrexone
Anti-Obesity Product, Chemotherapeutic / Anti-Neoplastic, Drug Research & Development API Tags: Obesity Sep 14, 2018
Naltrexone is typically administered to those who have a history of substance abuse, namely opiates or alcohol. The drug works to block the intensity of the drugs, so people are less likely to associate them with euphoria or pain relief. Because drug use in this country is still so stigmatized, it’s difficult to separate public[…]